Is the information provided by amino acid PET radiopharmaceuticals clinically equivalent in gliomas?

Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1408-1410. doi: 10.1007/s00259-017-3710-8. Epub 2017 Apr 27.

A Verger^{1

2

3}, D Taieb^{4

5}, E Guedj^{4

5

6}

¹ Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, Aix-Marseille Université, Timone University Hospital, Marseille, France. a.verger@chru-nancy.fr.
² Department of Nuclear Medicine & Nancyclotep Imaging Platform, CHRU Nancy, Lorraine University, Nancy, France. a.verger@chru-nancy.fr.
³ IADI, INSERM, UMR 947, Lorraine University, Service de Médecine Nucléaire, rue du Morvan, 54500, Vandoeuvre-les, Nancy, France. a.verger@chru-nancy.fr.
⁴ Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, Aix-Marseille Université, Timone University Hospital, Marseille, France.
⁵ CERIMED, Aix-Marseille Université, Marseille, France.
⁶ Institut de Neurosciences de la Timone, UMR 7289, CNRS Aix-Marseille Université, Marseille, France.

No abstract available

Publication types